Skip to main content
logo
Kane Biotech Inc. (TSXV:KNE)
Canada flag Canada · Delayed Price · Currency is CAD
0.0200
-0.0100 (-33.33%)
Aug 10, 2026, 3:31 PM EST

Kane Biotech Revenue

Kane Biotech had revenue of 43.22K CAD in the quarter ending March 31, 2026, a decrease of -89.52%. This brings the company's revenue in the last twelve months to 58.57K, down -97.60% year-over-year. In the year 2025, Kane Biotech had annual revenue of 427.87K, down -79.44%.

Revenue (ttm)
58.57K
Revenue Growth
-97.60%
P/S Ratio
70.02
Revenue / Employee
n/a
Employees
n/a
Market Cap
4.10M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025427.87K-1.65M-79.44%
Dec 31, 20242.08M1.93M1,296.75%
Dec 31, 2023148.98K-2.52M-94.42%
Dec 31, 20222.67M1.06M65.97%
Dec 31, 20211.61M266.20K19.84%
Dec 31, 20201.34M-351.95K-20.78%
Dec 31, 20191.69M1.19M234.51%
Dec 31, 2018506.27K85.80K20.41%
Dec 31, 2017420.47K298.90K245.87%
Dec 31, 2015121.57K--
Dec 31, 2014---
Dec 31, 2013159.95K--
Dec 31, 2011---
Dec 31, 2010---
Dec 31, 2009---
Dec 31, 2008---
Dec 31, 2007---
Dec 31, 2006---
Dec 31, 2005---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Kane Biotech News

More News